Loading clinical trials...
Loading clinical trials...
Treatment of Persistent Atrial Fibrillation With the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System
Conditions
Interventions
Mapping and Ablation
Locations
23
United States
Arrhythmia Institute at Grandview
Birmingham, Alabama, United States
Banner University Medical Center Phoenix
Phoenix, Arizona, United States
Arrhythmia Research Group
Jonesboro, Arkansas, United States
Pacific Heart Institute
Santa Monica, California, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
Naples Heart Institute
Naples, Florida, United States
Start Date
December 14, 2021
Primary Completion Date
January 10, 2024
Completion Date
January 10, 2024
Last Updated
April 23, 2025
NCT05147792
NCT06935591
NCT05963698
NCT03546374
NCT04947657
NCT06686485
Lead Sponsor
Medtronic Cardiac Ablation Solutions
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions